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Hector C. Ramos. MD; SaLom Todo. MD; Yoogoo Kang. MD; Evangelos Felekouras, MD; 
Howard R. Doyle, MD; Thomas E. Starzl, MD 
Olt •• etlv ••• To examine the techniques and the out-
come of liver transplantation with maximal conservation 
of blood products and to analyze the potential benefits or 
drawbacks of blood conservation and salvage techniques. 
D •• i9n. Case series survey. 
S.ttlng. Tertiary care, major university teaching hospital. 
Patl.n" anti M ......... Four patients with religious 
objections to blood transfusions who were selected on 
t he basis of restrictive criteria that would lower their risk 
for fatal hemorrhage, including coagulopathy. a throm-
bosed splanchnic venous system requiring extensive re-
construction. active bleeding, and associated medical com-
plications. All patients were pretreated with erythropoietin 
to increase production of red blood cells. All operations 
were performed at the same institution, with a 36-
month follow-up. 
• ......,.ntI ... OrthotopiC liver transplantation that used 
blood salvage, plateletpheresis. and autotransfusion and 
t he withholding of the use of human blood products with 
the exception of albumm. 
Main Ouko •• M_.ure •• Survival and postopera-
tive complications, with the effectiveness of erythropoi-
etin and plateletpheresis as secondary measures. 
R •• ul ... All patients are alive at 36 months after ortho-
topic liver transplantation. One patient, a minor (13 years 
of age), was transfused per a state court ruling. Erythro-
poietin increased the production of red blood cells as shown 
by a mean increase in hematocrit levels of 0.08. Platelet-
pheresis allowed autologous. platelet-rich plasma to be avail-
able for use after allograft reperfusion. Three major com-
plications were resolved or corrected without sequelae. 
Only one patient developed postoperative hemorrhage, 
which was corrected surgically. The mean charge for blood-
less surgery was $174 000 for the three patients with United 
Network for Organ Sharing (UNOS) status 3 priority for 
transplantation. This result was statistically Significant when 
these patients were compared with all the patients with 
UNOS status 3 priority during the same period who met 
the same restrictive gUidelines (P<.OS). Only 19 of 1009 
orthotopic liver transplantations performed at our insti-
tution were similiar according to the UNOS status and the 
fulfillment of the guidel·nes. The mean charge for these 
comparison patients was $327 000,3.8% of which was re-
lated to transfusions . 
Conelu.lon •• Orthotopic liver transplantation without 
the use of blood products is possible. Blood conservation 
techniques do not increase morbidity or mortality and can 
result in fewer transfusion-related, in-hospital charges. 
(Arch pur~K 1994; 129:528-533) 
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factors mlluencmg the outcome of this op-
eration is the amount of blood and blood 
products reqUIred. The operation has re-
4ulred a mean of 10 U of whole blood or 
packed red blood cells, I but at times up to 
300 U have been used. Most centers have 
found this amount of blood extremel\' t:lX-
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See Patients and Methods 
on next page 
PATIENTS AND METHODS 
PATIENT POPULATION 
From October 1990 to July 1993. 1009 transplantations m 
adult patients were performed at the Universitv of Pitts-
hurgh \1edical Center. During this penod. four patients who 
were Jehovah's Witnesses underwent liver transplantation 
under a specific protocol geared to perform a successful. 
hloodless procedure. Characteristics of the four patients are 
shown In T.It •• I . 
PATIENT SELECTION 
All patients were selected and their conditions evaluated 
hy a learn consisting of two transplantallon surgeons. 
two anesthesiologists. and a legal representative for the 
instilUllon. Restrictive gUidelines for the bloodless sur-
gery protocol were (I) hematocrIt level of 0.35 or less af-
tcr erythropoietin therapy: (2) platelet count of less than 
IOOOOOX lOolL: (3) prothrombin time of more than 15.0 
'ieconds: (4) known splanchnic venous anatomv that 
would requIre extensive vascular reconstructIOn at the 
time of transplantation: (5) aCllve hleeding: and (6) re-
nal failure and other major organ dvsfunction. Drugs 
that mav inhibit platelet function or coagulation were 
strictlv withheld. 
After selection. a meellng was held wllh the surgIcal 
team. familv members. religious counsel. and the anesthe-
siology staff. Treatment opllons. the pallent"s type and se-
verity of liver disease. and the details of the risks and the 
henefIts of transplantation. including the pOSSIbility of death. 
were explamcd. Acceptable hlood volume expanders were 
cal procedures. such as the coronarv arler\' bypass op-
erallon and other open-heart procedures. have not been 
transferred to the domam of liver transplantation.' ; "cv-
eral slUdles have addressed this issue, with varied re-
sults.;" hut a comprehenSive dfort to perform liver trans-
piantallons without blood products is not reported in the 
literature. This situation has led to the exclusion of pa-
Ilents wnh personal. religious. or scientific objections to 
transluslOn from possible li"er transplantallon. We pre-
sent the experience of the Ll1IVl'rsltv of Pittsburgh (Pal 
\kdical Center with scveral blood conser\'atlon tcch-
nlques In four patients who were Jehovah's Wit nesses. 
three 01 whom underwent lI\'er transplantatlon wnhollt 
t he use 01 h lood products, 
. \11 of our pauents survived the operallon and arc alive at 
preselll. rhe mean follow-up perIod was 3t) months, 
rhree of the patients had UNOS slatus 3 pnont\', 
,md one. with a diagnosis of fulmmant hepatic failure, 
discussed with the aid of the patient's religious counseL In 
all cases, the use of albumm. plateletpheresls. and cell sal-
vage with auto transfusion were acceptable. 
PRETRANSPLANTATION MANAGEMENT 
The patients were listed for orthotopIC liver transplanta-
tion by priority status. according to gUIdelines of the United 
Network for Organ Sharing WNOS)." Each pallentstarted 
therapy consisting of recombinant erythropoietin. 50 to 100 
Ulkg subcutaneously three times a week. and ferrous sul-
fate Fe 59.325 mg orallv three times a da\'. to increase pro-
duction of red blood cells. lOll Phytonadione therapy, 20 
mg subcutaneously, was also started to augment coagula-
tion. All blood tests were kept to a minimum. ie. blood was 
drawn twice in 6 weeks in pediatric vtals. using 1 mL of 
whole blood for routine laboratory evaluallons of hema-
tologic, chemistry, and coagulation status. 
INTRAOPERATIVE MANAGEMENT 
AND OPERATIVE TECHNIQUE 
Cold ischemia was kept to a minimum. Only local donors 
were used. The operating room was kept warm to avoid 
hypothermia and resultant coagulopathv. U 
All intraoperative blood sampling was also kept to a 
minimum, Laboratory evaluations included testing for ar-
terial blood gas. electrolyte. and hematocrIt levels and throm-
boelastographv. The thromboelastograph (Haemoscope, Hcl-
lige, Germany) was Ilsed as the prImary monitor of 
coagulation status. I! Plateletpheresis was performed after 
induction by phlehotomlzing 5 to 7 L of hloml at a flow 
Contlnllcd on ncxt page 
Ilad UNOS status 4 PrlOrlt\' at the lime of transplanta-
tion, All had significant Indica lIons lor urgent liver trans-
plantation <Table 11.,0 
The pallent with fulminant hepatiC failure (patient 4) 
a 13-year-old boy wnh a prothrombm time of 21.0 sec-
onds and a platelet count of 91000 X 10"/L received 2 l' 
of packcd rcd blood cells during the transplantation. Blood 
transfusion In t his patient was agreed to preoperativelv 
per a state court rulll1g. lie required rl'OperallOn for bleed-
ing 24 hours postoperatively hut did not undergo trans-
rusion at that tllne. 
One pallent developed pOSit ranspiantallon pulmo-
nary cdema. which later resolved \\lth diureSIs. Another 
pallent sustall1ed several lDplsode~ of hvpotenston dur-
Ing the opnatlon. rhe electroGlrdw!,!raplllc itndll1gs were 
consistent with a subendocardlal-mvocardial infarcllon 
and atnal fihrillation. Both prohlems responded to treat-
ment without sequelae . 
Tile re~ults 01 preOperatlVl' erythropOIetin therapy and 
plate1t-tpherests are illustrated in T.II •• 2. Only three 01 
the patients recelvcd the erythropOietin for of weeks or 
I!lUI 't·RGJ\·lll. 1':". \1.-\\' f"r~ 
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rate of 60 mUmin and processing through the platelet-
pheresis unit (Hemonellcs. Braintree. Mass).I' We esti-
mated that one pheresls product of 250 to 300 mL con-
tamed a platelet count of 3 X 1 O"IL to tl X LO"IL. to be infused 
after reperfusion. 
Filling pressures were optimized during the pheresls 
procedure with albumin. crystalloid solutions. and hv-
droxyethvl starch. Isovolemic hemodilution was therefore 
achieved in conJuncuon with the phlebotomy for the platelet-
pheresls. l ; Phlebotomized. platelet-poor blood was rein-
fused slowly to maintain oxygen-carrytng capacity. 
All incisions were made using electrocautery with a 
coagulation mode. The use of laparotomv sponges was kept 
to a mmimum to allow for the collection of as many red 
hlood cells as pOSSible before stable clots could form. When 
used. the sponges were drained into the field. and the drained 
hlood was collected with the cell-saver suction. The cell 
saver -+ (Hemonetics) and the Rapid Infusion System (He-
monellcs) were used for the salvage of red blood cells. In 
The nallve liver was removed in all patients. with the 
piggyback technique used in three patients 10 avoid dis-
sccllon of the retroperitoneal and retrocaval areas. I; An ar-
gon beam coagula lOr lBirtcher. Irvine. Calif) was used lib-
l'rallv to cauterize raw surfaces. Venovenous hypass. either 
pona\. systemic. or com hi ned. was used in all cases. 
On reperfusion of the liver and termmation of (he 
venovenous hvpass. platelet-nch plasma was slowly re-
tllrned to the patient. The blood from the venovenous 
hypass tuhing was dr:lIned directlv into the patient. This 
process returned hetween 200 and 250 mL of hlood per 
patient. 
.-\11 anastomoses were performed in standard fashion. 
I:xtra care was taken to usc smaller than usual slItures and 
smaller spacing to mllllmize hleeding from the anasto-
lllnger. \\llh a resultant mean lllcn:ase III the hemalOcnt 
kvclollH)H. Pattent of sustaineu a progressive decrease III 
hemalOcmlevel. uesplte ervthropOleun thempy, anu platclct-
pheresls was not useu uue to a low lIlllial platelet count. 
Estimates of operative hloou loss from inspection. re-
C lIVery III reu bloou u:lls 1ll the cell savers. ,1llU sponge 
wClghll1g were apprm(llllatclv 250 mL ror pallent l. ap-
proxlIllatclv 700 mL lor pallen! 2. ,1I1U appwxllnatclv 750 
IllL lur pallents 3 anu of. rhe lI1eall amount 01 recowreu 
.1IlU mnluseu reu blood cdls. notlnciuuing the phlcboLO-
111lzeu bloou for plateletphere~lsK was lcss than lOO mL in 
.tll pallents. Patient I had no transfus.lblc blood reco\'-
aeu. l)Wmg to a ~mall amount 01 ~urglcal bleeding. rhe 
11y-fel~mff~tf charges llithc stud\' p~lllcnts \\'lIh UNO'> sla-
IUS) Pfluntv were col11pared stallslIcallv \\'lIh the charges 
"I the I q lllmpanslln patients. rhe ulilcrence between the 
Illlalll1-hllSp"al chargcs was statlStlcallv signtlu.:ant ll'..:'lV5l. 
rhe mean amount 01 hlllOd products tr.mslused lor the l'll111-
panson group was 8.t'l2 U l)f packeu reu hlood cells. 7.')5 
l' 01 fresh rrozen plasma. and l) U III platelet concentratcs. 
rhe companson patients generateu 3.8% or their tOlal 
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mOllc sites. Jackson Pratt drains were left as monitors for 
hleedmg. These drains proved useful in identifying post-
operative bleeding in one pallent. 
Immunosuppression was mduced intraoperativelvwith 
tacrolimus (Prograftl. 0.05 mg/kg over 24 hours in a con-
tmuous intravenous mfusion. and methylprednisolone. I g. 
\1aintenance conicosteroid therapy consisted of 20 mg of 
methylprednisolone every 24 hours. An intravenous mfu-
sion of tacrolimus. 0.05 mg/kg, was continued until gas-
trointestinal function returned. 
In the immediate postoperative period, hemody-
namic monitoring and tluid management were performed 
in the standard way. All blood drawing was limited. Co-
agulation was mOnitored hy thromboelastography. pro-
thrombm time. and platelet count. Anv fibrinolysis was cor-
rected with E-ammocaproic aCid. I" 
\1inimal blood draWing gUIdelines were observed 
throughout the hospital stav. All pallents again received 
erythropOietin and ferrous sulfate Fe 59 until their hema-
wcnt levels rose to more than 0.35. 
STATISTICAL COMPARISON 
Of the 1009 pallents undergOing transplantation during the 
study penod. 445 were adults with UNOS status 3 pnor-
Ity: We reViewed the charts of these ++5 patients. search-
ing for patients who fulfilled our restrictive guidelines. Only 
19 of these patients met our gUidelines. All 19 patients un-
derwent transfUSIOn. The ill-hospital charges and the charges 
I'm the usc ofhlood products for aliI hese patients were com-
pared Wilh the charges of the corresponding group of 
Jehovah's Witnesses who underwent transplantation. The 
\\ann- Whitnev I 'lest was used for the stalls tical compari-
~on of I hese charges. 
charges lrom the bloou bank and the blood products. The 
charges ll)rcr.,thropoiettn thempy and platelctpheresls werc 
approXimately S 3000 lor each pallenl. but none exceeueu 
this amount. rhe charges ror erythropOietin therapy alonc 
were S 1500 per paticnt. 
\;ll III her surglGl1 endeavor rcqUlrcs as much attcntion to 
.Ind expertlsc \\'I\h blood l'llnser.'allon tcchniqucs as ma-
]llr surgical proceuures performeu on Jchovah's Wit-
Ilesscs. l)ur report Illuslrates thatcxcellent surVIVal for liver 
tran"plantallon ran be achievcd in these patIents. The iuea 
llf pcriorlmng a liver t ransplantal111n without blood is 
declllcd SllllnCllllll1l11n and dangerous that all pallel1lS With 
n:h~tous or eyen sClcnllfic objcctlOns to hlood transfusion 
11.l\T not hcen lllllS\(.lCfl·U Ill[ 1I\l'f tranSplal1lallon. IlllW-
l'\·er.thc tcchnlques lor perionnlllg this procedurc are avat\-
,Ible to us. ;lIld we have shown Ihal. wllh our stepWIse. mul-
lIdlsClplinar.' approach. this proccdure is posstble. 
Thc problem presentcd to us was Iwofold. Onc as-
\lH. lI .... l·oE~·y"ll1 1211 \1" IlJq,. 
no 
Table 1. Characteristics of Study Patients 
Patient No. 
2 3 4 
DiagnosIs Postnecrotic Primary biliary Alpha-. antitrypsin Fulminant hepatic 
cirrhosis cirrhosIs deficiency failure 
UNDS priority status' 3 3 3 4 
Age, y 58 46 19 13 
Previous surgery None None Central splenorenal None 
shunt 
cholecystectomy 
Immediate indication for Variceal Encephalopathy, Encephalopathy Fulminant failure 
orthotopic liver hemorrhage, weakness, vertebral 
transplantation encephalopathy compression 
fractures 
Albumin level, OIL 23 30 20 25 
Bilirubin level, 174,4 (10.2) 218.9 (12.8) 6.8 (0,4) 473.7 (27,7) 
J.LmoVL (mg/dL) 
Ascitest ++ ++ +++ ++ 
Grade of encephalopathy:!: 2 2 3 4 
'UNOS indicates United Network for Organ Sharing. See UNOS Board of Df(ectors.' 1991. for an explanation of UNOS pf/onty status for transplantation. 
t Two pIUS signs indicate requmng medical therapy: three plus signs. reqUlnng aggressive dIUretiC therapy WltIIlarge-volume paracentesIs, 
tFor enceohalopathy grades. 2 indicates alert With diminished level of conscIOusness: 3. altematlng stupor WltII agitation: and 4, coma, 
Table 2. Analysis of Blood Conservation Therapy 
Laboratory Values 
Hematocrit level 
At initial evaluation 0.26 
At transplantation 0.40 
Platelet count, xl 091L 
At transplantation 269000 
FollOWing plateletpheresls 161 000 
Postoperatively 225 000 
• NA InOlcates not aoollcable, 
peel \\'as ethical: Jehovah's \\'itnesses belie\'e lhat the lilt' 
Imcc IS contained In the bllllld. This hl'lIe! has a ~plDcllic 
,crlplllral basis,-,':I and their helief is protectl'd Iw legal 
precedl'n!.:! "'j Therefore, \\T as phvslctans cannot trans-
luse an adult jehovah's Witncss without Ills or hcr con-
,cnl. Parting fmm thaI prell1lse. pl'l'iorrlll11g a li\'l'r trans-
plantallon without blood products and \\'lIh the least 
.111101l11loi danger to the patlcnt was our second Illalor 
I..,SlIl'. II was clear tOllS 111 Ihe hegll1l11ng that lhl' l· ... tah-
Ilsllll1Cntlllll1lormcd conscnt was 01 Pflll1C Importance, 
Chis prlnuplc rcqUlred 1f~ lllllhlall1 a ... tatl' COllrt rliling 
Illr pallcllt -t. II,,' 11IIIWr el"i,l "I kllll\,lh ... \\·itnc"., Il;lr-
,·l1tS. who was In dire necd III ,Ilt\'l'r transplant. I he rul-
Il1g ,tlluwed u~ tll do our hC~ttll ~ayDlD thc llllld's Idc. In-
,luding thc lISC ,Ii hlood tr,lI1sluSIOI1S. \c\'crthde ...... ,til 
IcchnIques lor hlood consef\,\Illln were lIsed lust as \\lIh 
I he 01 her threc pallents. Whll"t'llperalillns were dom' \\'Ilh-
,Hi! thc ."lict\· IICt 01 a hlolllltransllhllll1, 
Ihe rCSlrtCI!\'C glllddll1cS werc linl'loped tll llicn-
Patient No. 
2 3 4* 
0.30 0.32 0,25 
0.39 0.45 0.23 
204000 255000 NA 
111 000 193000 NA 
185 000 202000 NA 
I dv slirglCal risks ror l'\sangUlI1allOn, III lact. WL' have cvalu-
,\led the casl'S 01 12 palll'lIts previollslv and continue to 
cvaluate cases lor thiS procedure. rWO 01 these patients 
have died 01 \'ariceal hcmorrhage: l'lght othcr cases arc 
,1\ variolls stages 01 naluallon. 
rreoperativr condlllol1lng was III the lItmost impor-
tance, Pallents WIl h Ii\'er (iIseasl' and rcsultant anemia, from 
L·lther chroniC blood 10"", lll' l'ilrtllllC dlsl'<be. are excellent 
candidatcs lor n\'thropolctln Ihcrap\,'" I'r\,dHopOletln 
I herap\' \\as 1I11l1ated rcgardllD~s olt he I I II e 1\';11 hctween cvalu-
.llIon and transplantallllil. although.!. weeks IS the usual 
lime \\' IlL'n Cl\'l h rnpOIl'111I .,1;\ rt SIll ... h ll\\' ,III l' IIcct. I I C;oou-
110ugh ct ai" have ... hm\ n that prcopnall\'C L'1\'lhropOlcun 
can IIIC1'case Ihe amount 01 allllllogllll., hlllLld 1[1 dec\l\'c 
'lrthopedlc procedures Prcopcr.lll\'C l'1\'throplllctin themp\' 
,lI1d the Ilmttalllln 01 phlehlltol11\' illr laboratory evalua-
tion showcd us that thiS was potentlall\, a malorareaofim-
pWWIlll'1l1. I1l1lllllh' 111 the Ichmah's \\'itlll'sses hltlll1 all 
,'andidates I(lr 1i\'Cr tr;l!1spiantatloll. 1l1traopcrauvciv. two 
IRLlI"'llll,l\(lI f~"I \lAY l'l<!-4 
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other problems were solved. One was diminishing the loss 
of red blood cells: the other was correcting coagulopathy. 
The monitoring and the correction of coagulopathy were 
the most difficult of these problems. Plateletpheresis al-
lowed us to conserve platelets. Several studies have shown 
J reduction in the need for blood translusion. fresh frozen 
plasma. and platelet concentrates with the use of autolo-
gous. platelet-rich plasma In cardiac surgery. ~~Kl!l Our trans-
fusions of autologous. platelet-rich plasma contained a mean 
platelet count of 4.5 X lO"/L for 300 to +00 mL. According 
to our blood bank. this amount is equal to 6 to 8 U from 
random donors. As can be seen in three of the four pa-
tients. the drop In the platelet count at the end of the pro-
cedure was minimal (Table 2). Again. this technique does 
not have to be limited to selected patients. 
Intraoperative cell salvage has been used exten-
sIvely in liver transplantationY Fortunatelv. the effect 
tlf cell salvage In our studv patients was underesllmated 
due to minimal bleeding. but the normovolemic hemo-
dilulion may have plaved an important role in minimiz-
ing the loss of red blood cells. The complications sus-
taIned by our patients are not uncommon in liver 
transplantation. yet their relationship to the blood con-
~ervallon techniques used remains unclear. 
In our current medical environment of managed care 
Jnd C\'Cr increaSIng fiscal concerns. other factors to be 
conSIdered are the charges generated bv the use of blood 
products. Our study group showed a SIgnificant de-
crease in the total in-hospital charges from the charges 
of the comparison group. Other centers have slUdied the 
charges for cell salvage alone and found a savings of S I HOO 
per pallent." Our results concur wllh this finding, and 
we believe that adding other blood conservatIon tech-
I1lques docs not add to the expense but rather enables 
t he conservation of blood. which 111 turn results 111 the 
gencr;1l10n 01 fewer transIuslOl1-rt'lated charges. 
In conclUSIOn. to perlorm lIvcr transplantation on 
khmah's Witnesses. we were able to ldenllh' several ex-
l..,lIng techniques tor bioOlI conservation that coulc.l ac.ld 
.\ lewl of efficiencv and salctv to all liver transplanta-
I lOI1S. and we propose the use of these techniques when-
cver Pllsslble. Whether using these techniques and us-
II1g less blood products IS (ost-ciTectl\'c WIll requIre tun her 
'Iulh. perhaps a random i:cd I rIal. 
l'rcsOIlCti til dIe 10IsI K~DflDfflfffE S,'S\WII 01 lite \\"nlClII 
~11fK~fE1f1 .. \sSO(lIlCl(lIl. Sellllie. \\'aslt. '\'o\"clllhrr I (1, I'I'H. 
l~qnl1ll reqllnls Itl .)lIlIe -Ie. .360 I Fillit A Ie. Pills-
1Flu~ltK I'. \ 1521.3 (/), 1~Dfff"ly I. 
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\1y second question is whether or not you have a protocol 
fur intraoperative Iluid therapy or replacement therapy in vour 
routme liver transplants. If so. what are the prinCiples? Do you 
use colloids? Who decides: you surgeons or the anesthesiolo-
gists? What would vou do If the Jehovah's Witness patient bleeds 
out of control? How much would you actuallv save in terms of 
money per patient If you could transplant without blood trans-
fusions? Please tell us how you resuscitate your clinical single-
llrgan diver) shock model. 
Mohammed Atik. MD. Los Angeles. Calif: The feat to 
use no blood in three of their four selected liver transplants IS 
indeed impreSSive: that they could do these complex opera-
tions with such a small amount of blood loss is even more re-
markable. Obviouslv their accomplishment is pnncipa\ly due 
to their operative planning and skill. Credit should also be given 
to their avoidance of transfusion of stored blood and the pen-
operative withdrawal and reinfusion of patients' own blood and 
platelets. There IS evidence that multiple transfusion of stored 
blood and platelet dysfunction augment coagulopatby and bleed-
Ing tendencies. It is well known that an Important Iimiung fac-
tor. beSides hematocrit. for oxygen delivery and tissue perfu-
sion. is the compensatory ability of the heart to mcrease cardiac 
llUtput In the face of blood loss. In the absence of cardiovas-
cular dvsfunctlon. a hematocrit of around 35% is optimum In 
normovoit:mlC patients. Most patients do well with a hemato-
crIt of 30'J:.,. and those Without cardiovascular and pulmonary 
disease Glll tolerate a hematocrit as low as 20% periopera-
llvelV, proVided their plasma volume IS maintained. These prin-
ciples demonstrated bv the authors arc also applicable to other 
areas of surgery. 
. \t UCL\. in ltl conseCUll\'e, elective reconstructive op-
erations for aneurysm and occlusive disease. we have used half 
JS much blood transfusions as III comparable operatwns re-
ported bv other well-respected medical centers (mean of 1.7 U 
\'S +'5 U 01 blood), More pertinent to this diSCUSSIOn, six of our 
pallenlS (or III one third of our patients), 110 blood or platelets, 
glftolEF~ou~ or otherwise, were used. w1Ih no ill effects. We could 
have dOlle hetter If we did not have unaVOidable blood loss (mean 
,111 O(1l1:!: +4) cc) due to use of porolls prostheSIS, lfushln~K and 
itl'parll1l:atlon .1I1o!l we <-lid not oeal with older patlents (lllc.lIl 
Kf~e 01 ()4:!:! \'ears) with conSiderable cardiovascular discase 
.Intllimlled cartllac compensator.' mechanism to wlerate a low 
hcmalOcnt, l hlr expenenee with these operatIOns, all pcr-
formed by residents under superviSIOn, though not as spec-
tacular as that of the authors. confirms their findings and dem-
onstrates that complex operations, traditlonallv performed with 
several units of blood. can be performed safely with little or no 
blood transfusions, 
Dr Ramos: First of all, Dr Dawldson, we were not allowed 
to use FFP in our patients. only albumin and hetastarch. That 
is why we mcluded PT greater than 15 in the restrictive guide-
lines, We are presently undergomg plans lor a randomized trial 
of cell salvage and these techniques in the average liver trans-
plant. Unfortunately we have found a bit of resistance from sev-
eral of our surgeons, but I think that we wtll be able to over-
come this resistance, 
The intraoperative management of fluids IS managed by 
Anesthesia. Dr Kang is a world-class liver transplant anesthe-
siologist and has published extensivelv on both cell salvage and 
on resuscitation and coagulation in liver transplantation. He 
was the anestheSiologist of record in all of these cases. 
The question is, what would we do if the pallent starts bleed-
ing uncontrollably? There is only one thing legally we could have 
done. and that is to pray. The rights of these patients are pro-
tected by legal precedent, and we are not allowed to transfuse an 
adult Jehovah's Witness, If we do. It is assault. Dr Roger Jenkins 
from Massachusetts has published a paper usmg cell salvage alone 
and found a $1800 savings in orthotopic liver transplants in about 
40 cases. He didn't transplant Jehovah's Witnesses. but his av-
erage blood utilization was approximatelv 35 U. 
We optimize filling prcssures by usmg +-5 L of crystal-
loid. The isovolemlc hemodilulion takes place In actually ev-
ery liver transplant because these patients have not eatcn or drunk 
fluids for about 24 hours: when they come to the operaung room . 
they are fairly dchydrated, Their hcmatocnts are high. If we 
llptimize filling pressures with 1.-+ L of either albumin or he-
tastarch or cven crystalloid, we GlI1 obtam hIgh oxygen trans-
ports in thcse pallents who, by virtue tll their portal hyperten-
sion, already have t'Olrdlac outputs that arc mcreased to 8-10 L. 
We can obtain llxvgen transports between HOO mL to 1000 mL 
per minute. fhe hematoCrit nl 35% was chllsen arbtlranlv by 
,Igreement he tween our departments. 
rhl' qUl',IIUll ahout \\'hrtha tillS should hc llsed for everY 
liver transplant IS exactlv wlw I wrote tillS paper. I have learned 
a Illt from doing these patients. Unforlunatl'lv. ,mce 1991, we 
haven't lound one to itt our restnctlve gUlodlnes. 
Conversions from Systime International (SI) Units to Conventional Units (Modified from The 51 Mlnul' in Hlllth Care) 
SI Conversion Conventional 
Reference SI Factor Reference Conventional 
System" Compo ..... Intemlt Unlit (Divide by) Inlemlt Unit 
S Albumin 40-60 giL 10.0 4.0-6.0 gloL 
B Hematocnt 
Female 0.33-{).43 0.01 33-43 
'. Male 0.39-0.49 1 0.01 39-49 
'. B ThrombOCytes (platelets) 15G-4SO 1(1A- 150-450 l()l/cu mm 
, 8 re(Jresents IJlood: S, serum, 
t These reference values are not mteflOecI to lJe definitive smce eaclllalJoratory determmes Its own values. They are (Jrovlded for Illustration onlV 
tAn araolc one m tillS column mdlcates tIIat tillS Item. formerty eX()fessea m (Jercent, SlJOuld lJe eX(Jressea as a decimal lor the a(J()fo(Jflare (Jan or 1/ 
,\RCli SLRGIVOL ll'l. MAY 1<N4 
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